| scholarly article | Q13442814 |
| P50 | author | Geoffrey Buckle | Q37392441 |
| John Vulule | Q55207459 | ||
| Jodi L. Skiles | Q55209215 | ||
| P2093 | author name string | Scot C Remick | |
| Terry A Vik | |||
| Ann M Moormann | |||
| Louise Maranda | |||
| Juliana A Otieno | |||
| Jeffrey A Bailey | |||
| John Michael Ong'echa | |||
| Joslyn Foley | |||
| Andrew Schroeder | |||
| Alan Rosmarin | |||
| Jennifer Lemberger | |||
| Mara Epstein | |||
| P2860 | cites work | 2000 CDC Growth Charts for the United States: methods and development | Q29614506 |
| The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma | Q34028372 | ||
| Burkitt's lymphoma | Q34030708 | ||
| Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study | Q34071474 | ||
| Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting | Q34549509 | ||
| Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease | Q36201443 | ||
| Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells | Q36327307 | ||
| The evolving management of Burkitt's lymphoma at Red Cross Children's Hospital. | Q36640938 | ||
| Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer | Q37316016 | ||
| Factors influencing time to diagnosis and initiation of treatment of endemic Burkitt Lymphoma among children in Uganda and western Kenya: a cross-sectional survey | Q37362355 | ||
| Results of treatment with CMA, a low intermediate regimen, in endemic Burkitt lymphomas in sub-Saharian Africa: experience of Côte d'Ivoire | Q37756027 | ||
| Practical recommendations for the management of children with endemic Burkitt lymphoma (BL) in a resource limited setting | Q38063477 | ||
| Two overlooked contributors to abandonment of childhood cancer treatment in Kenya: parents' social network and experiences with hospital retention policies | Q38208783 | ||
| Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infection | Q38875586 | ||
| Prognostic significance of biochemical markers in African Burkitt’s lymphoma | Q38880748 | ||
| Long‐term experience with burkitt's lymphoma in uganda | Q38892656 | ||
| Treatment of B-cell lymphoma with LMB modified protocols in Africa--report of the French-African Pediatric Oncology Group (GFAOP). | Q39047996 | ||
| Abandonment of childhood cancer treatment in Western Kenya | Q39199136 | ||
| A “Tumour Safari” in East and Central Africa | Q39909919 | ||
| Cyclophosphamide monotherapy in children with Burkitt lymphoma: A study from the French–African Pediatric Oncology Group (GFAOP) | Q41431405 | ||
| Malawi pilot study of Burkitt lymphoma treatment | Q44033126 | ||
| EBV viral load in tumor tissue is an important prognostic indicator for nasal NK/T-cell lymphoma | Q45149335 | ||
| The 2000 Burkitt lymphoma trial in Malawi | Q45153040 | ||
| Nutritional status at admission of children with cancer in Malawi | Q45172995 | ||
| Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies | Q45182739 | ||
| Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children | Q45496126 | ||
| Circulating Cell‐Free Epstein‐Barr Virus DNA Levels in Patients with EBV‐Associated Lymphoid Malignancies | Q45734816 | ||
| Epstein-Barr virus DNA quantitation assessed by a real-time polymerase chain reaction in a case of Burkitt's lymphoma. | Q45737167 | ||
| Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi | Q46065716 | ||
| Endemic Burkitt lymphoma: a 28-day treatment schedule with cyclophosphamide and intrathecal methotrexate | Q46119455 | ||
| Long term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapy | Q46989416 | ||
| Spatial clustering of endemic Burkitt's lymphoma in high-risk regions of Kenya | Q48036251 | ||
| c-myc hypermutation is ongoing in endemic, but not all Burkitt's lymphoma. | Q53854593 | ||
| Prognostic factors in Burkitt's lymphoma importance of total tumor burden | Q53962749 | ||
| Simplified calculation of body-surface area. | Q55060911 | ||
| Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution | Q69943426 | ||
| Geographic distribution of Burkitt's lymphoma | Q93648093 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Burkitt lymphoma | Q1016605 |
| Kenya | Q114 | ||
| P304 | page(s) | 1231-1240 | |
| P577 | publication date | 2016-05-02 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study | |
| P478 | volume | 139 |
| Q64360648 | A Cross-Sectional Population Study of Geographic, Age-Specific, and Household Risk Factors for Asymptomatic Malaria Infection in Western Kenya |
| Q94564208 | A New Hope for CD56negCD16pos NK Cells as Unconventional Cytotoxic Mediators: An Adaptation to Chronic Diseases |
| Q33834535 | Beyond Endemic Burkitt Lymphoma: Navigating Challenges of Differentiating Childhood Lymphoma Diagnoses Amid Limitations in Pathology Resources in Lilongwe, Malawi |
| Q33887891 | Cancer trials in sub-Saharan Africa: Aligning research and care. |
| Q38808086 | Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences |
| Q98719925 | Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa |
| Q64064157 | Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma |
| Q62490169 | How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa |
| Q37723512 | Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma |
| Q89770486 | Kaposi Sarcoma-associated herpesvirus infection and endemic Burkitt's lymphoma |
| Q50140468 | Lymphoma and Pathology in Sub-Saharan Africa: Current Approaches and Future Directions |
| Q57164769 | Pediatric Cancer in Northern Tanzania: Evaluation of Diagnosis, Treatment, and Outcomes |
| Q90139894 | Perspective: Creating the Evidence Base for Nutritional Support in Childhood Cancer in Low- and Middle-Income Countries: Priorities for Body Composition Research |
| Q40304324 | Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi |
| Q56380040 | Poorly cytotoxic terminally differentiated CD56CD16 NK cells accumulate in Kenyan children with Burkitt lymphomas |
| Q36235726 | Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study |
Search more.